Aug 1, 2019 Syros Reports Second Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
May 7, 2019 New Publication in Cancer Research Highlights Discovery of SY-1365, a First-in-Class Selective CDK7 Inhibitor, and its Promise as a Potentially Transformative Targeted Approach for Difficult-to-Treat Cancers
May 1, 2019 Syros Reports First Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
